TMPRSS2-Inhibitors Play a role in Cell Entry Mechanism of COVID-19: An Insight into Camostat and Nafamostat
Journal Title: Journal of Regenerative Biology and Medicine - Year 2020, Vol 2, Issue 2
Abstract
The enzymes trypsin, furin and other proprotein-convertasen, cathepsin, transmembrane proteases (TMPRSS) and elastases play a role by the cell entry of Coronaviren (Coronaviridae)[1]. The proteases TMPRSS2 and TMPRSS11a, which exist in the respiratory tract richly and become experiment on cell surfaces, promote the entry of SARS-CoV-1-virus. For the TMPRSS-protease TMPRSS11d - also as protease similar to trypsin has confessed of the human respiratory tract - a proteolytic activation of the spike protein was proved by SARS-CoV [2]. TMPRSS2 again makes a complex reaction with the ACE2 receptor what allows an efficient penetration of the virus directly in the cell surface [2,3]. TMPRSS2 and TMPRSS11D activate the spike protein, while they split it in the S1 and S2 subunits by which an endosome independence cell entry is allowed in the cell membrane [2,3]. Virus-based therapies enclose monoclonal antibodies, an anti-viral peptide which docks to the spike protein of viruses, inhibitors of the viral nucleic acid synthesis and inhibitors for docking to other viral structures and accessory proteins. Different known serine inhibitors do exist: Gabexate mesylate (Tokyo Chemical Industry, Tokyo, Japan), Nafamostat mesylate (Tokyo Chemical Industry), Camostat mesylate (Wako, Tokyo, Japan), Sivelestat sodium tetrahydrate (LKT Laboratories, St. Paul, MN, USA), rivaroxaban (Adooq Bioscience, Irvine, CA, USA) Telaprevir (Adooq Bioscience) and Simeprevir (TRC, Toronto, Canada) were dissolved in DMSO at a concentration of 10 mm Ulinastatin (Mochida Pharmaceutical Co. Ltd. Tokyo, Japan) was dissolved in PBS (-) which lacked Mg2+ and Ca2+. The FDA approved drug library (L1300) was purchased from Selleck (Houston, TX, USA) and diluted in DMSO at a concentration of 100 μM. Especially in COVID-19, we took a closer look on two main serine protease inhibitors.
Authors and Affiliations
Stefan Bittmann*, Elisabeth Luchter, Anne Weissenstein, Gloria Villalon and Elena Moschüring-Alieva
Keywords
Related Articles
- EP ID EP707325
- DOI https://doi.org/10.37191/Mapsci-2582-385X-2(2)-022
- Views 62
- Downloads 0
Anti-inflammatory and Antifibrotic Effects of Plant Regulatory Peptides in Patients with Steatohepatitis and Cirrhosis: Opportunities of Primary Liver Cancer Prevention
The pathogenesis of steatohepatitis, which develops on the background of non-alcoholic fatty liver disease and may be the cause of liver cirrhosis, is considered in the article. Also, the paper focuses on the prospects o...
Techniques for Research in Deer Antlers, the Sole Mammalian Organ which undergoes Epimorphic Regeneration
The annual renewal of deer antlers offers the only opportunity to learn how nature has solved the problem of mammalian organ regeneration. Promotion of the antler model to the field of regenerative biology and medicine,...
L-PRF in Osteoarthritis Treatment: Results of a Pilot Study
Osteoarthritis (OA) is the most common chronic musculoskeletal disorder and is the most frequent single cause of disability in older adults [1]. OA is a chronic disease progressively involving the entire joint. Progressi...
Alice in Wonderland Syndrome: An Update of Present Data with a Special View to Body Position, Traumatic and Genetic Aspects
Alice in Wonderland Syndrome (AIWS) was named after the description of Lewis Carroll in his novel. In 1955, John Todd, a psychiatrist described this entity for the first time and results in a distortion of perception. To...
TMPRSS2-Inhibitors Play a role in Cell Entry Mechanism of COVID-19: An Insight into Camostat and Nafamostat
The enzymes trypsin, furin and other proprotein-convertasen, cathepsin, transmembrane proteases (TMPRSS) and elastases play a role by the cell entry of Coronaviren (Coronaviridae)[1]. The proteases TMPRSS2 and TMPRSS11a,...